Mastek is currently trading at Rs. 3025.40, up by 27.10 points or 0.90% from its previous closing of Rs. 2998.30 on the BSE.
The scrip opened at Rs. 2987.50 and has touched a high and low of Rs. 3083.35 and Rs. 2970.00 respectively. So far 4843 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3147.00 on 16-Feb-2024 and a 52 week low of Rs. 2105.95 on 26-Oct-2023.
Last one week high and low of the scrip stood at Rs. 3083.35 and Rs. 2927.15 respectively. The current market cap of the company is Rs. 9348.02 crore.
The promoters holding in the company stood at 36.25%, while Institutions and Non-Institutions held 21.15% and 42.60% respectively.
Mastek has entered into a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions. This collaboration aims to expedite the adoption of FHIR (Fast Healthcare Interoperability Resources) standards, driving enhanced data interoperability and ultimately better health outcomes for patients.
In an era where seamless data exchange is critical for effective healthcare delivery, the partnership between Mastek and Onyx Health will provide health plans with an out-of-the-box compliance solution for CMS-9115 (Patient Access API) and CMS-0057 (Advancing Interoperability and Electronic Prior Auth) rules. These regulations, pivotal to modernizing healthcare data exchange, require health plans to ensure secure, standardized data sharing across systems. Mastek and Onyx Health are at the forefront of delivering comprehensive solutions to meet these stringent regulatory requirements efficiently and effectively.
This strategic partnership represents a significant step forward in addressing the interoperability challenges faced by the healthcare industry. By combining the strengths of Mastek and Onyx Health, this collaboration promises to deliver innovative solutions that will shape the future of healthcare data exchange.
Mastek together with its subsidiaries, provides enterprise technology solutions and platforms for insurance, government, and financial services organizations worldwide.
| Company Name | CMP |
|---|---|
| TCS | 4167.95 |
| Infosys | 1916.55 |
| HCL Tech. | 1891.65 |
| Wipro | 309.10 |
| Tech Mahindra | 1711.80 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
